Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
110-nitro-9(E)-octadec-9-enoic acid1件: CXA-10---1件: 86 💬
211C-acetate1件: Acetic acid C-11---3件: 13, 86, 88 💬
3120 MG sodium nitrite inhalation solution----1件: 86 💬
4129XE hyperpolarized----1件: 86 💬
515 MG sodium nitrite inhalation solution----1件: 86 💬
6150MG CXA-10----1件: 86 💬
718F-fgln PET imaging----1件: 86 💬
82-(4-[5,6-diphenylpyrazin-2-YL)(isopropyl)amino]butoxy)-N-(methylsulfonyl)actamide----1件: 86 💬
92-hoba1件: 2-(aminomethyl)phenol---2件: 46, 86 💬
102-{4-[(5,6-diphenylpyrazin-2-YL)(isopropyl)amino]butoxy}-N-(methylsulfonyl) acetamide----1件: 86 💬
1120 MG/ML treprostinil1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1225% MTD sodium nitrite inhalation solution----1件: 86 💬
13400 MG BIA 5-1058----1件: 86 💬
1445 MG sodium nitrite inhalation solution----1件: 86 💬
154au76----1件: 86 💬
166-minute walk distance (6MWD) test----2件: 86, 88 💬
176-minute walk distance (6MWD) test ON ambient AIR----2件: 86, 88 💬
186-minute walk distance test with supplemental oxygen----2件: 86, 88 💬
1966215-101----1件: 86 💬
206R-BH41件: Sapropterin2件: Sapropterin dihydrochloride ,
Sapropterin 💬 		--2件: 86, 124 💬
2175MG CXA-10----1件: 86 💬
2290 MG sodium nitrite inhalation solution----1件: 86 💬
23Access program - sildenafil citrate, viagra, revatio----1件: 86 💬
24ACE-011----1件: 86 💬
25ACE-011 / ??-7962----1件: 86 💬
26ACE-011 / MK - 7962----1件: 86 💬
27ACE-011 / MK-7962----1件: 86 💬
28ACE-011/ MK-7962----1件: 86 💬
29Acetaminophen1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬14件: 11, 19, 34, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
30ACT - 064992----1件: 86 💬
31ACT-050089----1件: 86 💬
32ACT-064992----5件: 51, 85, 86, 88, 210 💬
33ACT-064992 / JNJ-67896062----1件: 86 💬
34ACT-064992/ JNJ-67896062----1件: 86 💬
35ACT-064992D----1件: 86 💬
36ACT-178418----1件: 86 💬
37ACT-293987----3件: 51, 86, 88 💬
38ACT-385781A----1件: 86 💬
39Actriia-IGG1FC----1件: 86 💬
40Adcirca1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
41Adcirca 20 MG FILM-coated tablets1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
42Adempas1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬5件: 51, 86, 88, 225, 299 💬
43Adempas 0.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299 💬
44Adempas 1 MG film coated tablet1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
45Adempas 1.0 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299 💬
46Adempas 1.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
47Adempas 1.5 MG film coated tablet1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
48Adempas 2 MG film coated tablet1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
49Adempas 2.0 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299 💬
50Adempas 2.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
51Adempas 2.5 MG film coated tablet1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
52Adempas filmtabletten1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
53Adempas® 0.5 MG FILM-coated tablets1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
54Adempas® 1.0 MG FILM-coated tablets1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
55Adempas® 1.5 MG FILM-coated tablets1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
56Adempas® 2.0 MG FILM-coated tablets1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
57Adempas® 2.5 MG FILM-coated tablets1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
58Adempas¿ 0.5 MG compressa rivestita CON film1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
59Adempas¿ 1.01件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
60Adempas¿ 1.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
61Adempas¿ 2.0 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
62Adempas¿ 2.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
63Adipose derived mesenchymal stem cells----1件: 86 💬
64AER-901 solution FOR nebulization----1件: 86 💬
65Aerosolized iloprost----1件: 86 💬
66AIR001----1件: 86 💬
67AIR001 inhalation solution----1件: 86 💬
68Albuterol1件: Albuterol2件: Albuterol sulfate ,
Albuterol 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 12, 13, 86, 113, 231, 256, 299, 340 💬
69Allogeneic human cardiosphere-derived stem cells----1件: 86 💬
70Ambrisentan1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 51, 66, 84, 85, 86, 88, 210, 211 💬
71Ambrisentan - high dose1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
72Ambrisentan - LOW dose1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
73Ambrisentan 5 MG FILM-coated tablets1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
74Ambrisentan mimic1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
75Ambrisentan plus spironolactone1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
76Ambrisentan tablet1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
77AMN107----2件: 34, 86 💬
78Anakinra1件: Anakinra1件: Anakinra 💬 2件: IL1R1,
IL1R2 💬 		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬19件: 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬
79Anastrozole1件: Anastrozole1件: Anastrozole 💬 1件: CYP19A 💬 2件: Ovarian steroidogenesis, Steroid hormone biosynthesis 💬3件: 78, 86, 193 💬
80Apabetalone1件: Apabetalone1件: Apabetalone 💬 --1件: 86 💬
81APD811----1件: 86 💬
82Apelin1件: Apelin---1件: 86 💬
83APL-9796----1件: 86 💬
84AR392830----1件: 86 💬
85Artesunate1件: Artesunate1件: Artesunate 💬 --4件: 18, 66, 86, 96 💬
86Aspirin1件: Acetylsalicylic acid1件: Aspirin 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬12件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231, 271 💬
87Assigned pulmonary hypertension medication----1件: 86 💬
88AV-1011件: AV-101---2件: 6, 86 💬
89Aviptadil1件: Aviptadil1件: Aviptadil 💬 --4件: 49, 51, 84, 86 💬
90AZD4831----1件: 86 💬
91Background PAH therapy----1件: 86 💬
92Bardoxolone methyl2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬 		--5件: 67, 84, 85, 86, 218 💬
93Bardoxolone methyl capsules2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬 		--4件: 66, 67, 86, 222 💬
94BAY 63-2521----2件: 86, 88 💬
95BAY 63-2521 coated tablets 0.5 MG----2件: 86, 88 💬
96BAY 63-2521 coated tablets 1 MG----2件: 86, 88 💬
97BAY 63-2521 coated tablets 1.5 MG----2件: 86, 88 💬
98BAY 63-2521 coated tablets 2 MG----2件: 86, 88 💬
99BAY 63-2521 coated tablets 2.5 MG----2件: 86, 88 💬
100BAY 63-2521 IR tablets 0.5 MG----1件: 86 💬
101BAY 63-2521 IR tablets 1 MG----1件: 86 💬
102BAY 63-2521 IR tablets 1.0 MG----1件: 86 💬
103BAY 63-2521 IR tablets 1.5 MG----1件: 86 💬
104BAY 63-2521 IR tablets 2.0 MG----1件: 86 💬
105BAY 63-2521 IR tablets 2.5 MG----1件: 86 💬
106BAY 63-2521 tablet----1件: 86 💬
107BAY 63-2521 tablets 0.5 MG----2件: 86, 88 💬
108BAY 63-2521 tablets 1 MG----2件: 86, 88 💬
109BAY 63-2521 tablets 1.5 MG----2件: 86, 88 💬
110BAY 63-2521 tablets 2 MG----2件: 86, 88 💬
111BAY 63-2521 tablets 2.5 MG----2件: 86, 88 💬
112BAY Q 6256----1件: 86 💬
113BAY1237592----2件: 86, 88 💬
114BAY63-2521----4件: 51, 86, 88, 299 💬
115Beetroot juice----1件: 86 💬
116Benzbromaron AL----1件: 86 💬
117Benzbromarone1件: Benzbromarone1件: Benzbromarone 💬 --1件: 86 💬
118Beraprost1件: Beraprost2件: Beraprost sodium ,
Beraprost 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
119Beraprost sodium1件: Beraprost2件: Beraprost sodium ,
Beraprost 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
120Beraprost sodium 314D modified release tablets1件: Beraprost2件: Beraprost sodium ,
Beraprost 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
121Beraprost sodium modified release1件: Beraprost2件: Beraprost sodium ,
Beraprost 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
122BIA 5-10581件: BIA---1件: 86 💬
123BIA-5-10581件: BIA---1件: 86 💬
124Biological dmards----2件: 86, 107 💬
125Bisoprolol1件: Bisoprolol2件: Bisoprolol fumarate ,
Bisoprolol 💬 		1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 58, 67, 86, 113 💬
126Bosentan1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬11件: 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
127Bosentan administration1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
128Bosentan dispersible tablets1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
129Bosentan monohydrat1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
130Bosentan monohydrate1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 51, 84, 86, 88 💬
131Bosentan, ambrisentan1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
132BPS-314D-MR----1件: 86 💬
133BPS-MR----1件: 86 💬
134Breelib nebulizer----1件: 86 💬
135Bromure D'ipratropium----1件: 86 💬
136BSF 208075----1件: 86 💬
137BSF 208075 or LU 208075----1件: 86 💬
138C07ab07----1件: 86 💬
139C225----2件: 51, 86 💬
140Calcifediol oral capsule1件: Calcifediol1件: Calcifediol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 86 💬
141Capsaicin1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬4件: 2, 6, 86, 226 💬
142Captopril1件: Captopril1件: Captopril 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬2件: 17, 86 💬
143Carbon monoxide2件: Activated charcoal,
Carbon monoxide		2件: Charcoal, activated ,
Carbon monoxide 💬 		--1件: 86 💬
144Cardiomems pulmonary artery pressure monitor----1件: 86 💬
145Carvedilol1件: Carvedilol2件: Carvedilol ,
Carvedilol phosphate 💬 		5件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2 💬 		15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 6, 46, 57, 86, 113, 210 💬
146Cetuximab1件: Cetuximab1件: Cetuximab 💬 1件: EGFR 💬 47件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Virion - Hepatitis viruses 💬5件: 34, 51, 86, 89, 331 💬
147Chlorhexidine1件: Chlorhexidine4件: Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate 💬 		--1件: 86 💬
148Cialis1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
149Cialis 10 MG FILM-coated tablets1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
150Cialis 2.5 MG FILM-coated tablets1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
151Cialis 20 MG comprimidos recubiertos CON PELícula1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
152Cialis 20 MG FILM-coated tablets1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
153Cialis 5 MG FILM-coated tablets1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
154Cicletanine1件: Cicletanine2件: Cicletanine ,
Cicletanine hydrochloride 💬 		--1件: 86 💬
155Cicletanine hydrochloride1件: Cicletanine2件: Cicletanine ,
Cicletanine hydrochloride 💬 		--1件: 86 💬
156Clopidogrel1件: Clopidogrel4件: Clopidogrel bisulfate ,
Clopidogrel ,
Clopidogrel hydrochloride ,
Clopidogrel besilate 💬 		1件: P2RY12 💬 3件: Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬4件: 40, 49, 51, 86 💬
157Cmri----3件: 51, 77, 86 💬
158Coenzyme Q-10 IN normal control subjects1件: Ubidecarenone1件: Ubidecarenone 💬 --1件: 86 💬
159Coenzyme Q-10 IN pulmonary hypertension subjects1件: Ubidecarenone1件: Ubidecarenone 💬 --1件: 86 💬
160Confirm RX----1件: 86 💬
161Crono five ambulatory pump----1件: 86 💬
162CS1----1件: 86 💬
163CS1 administration----1件: 86 💬
164CXA-101件: CXA-10---2件: 86, 222 💬
165D-glucose1件: D-glucose---2件: 86, 88 💬
166D.3.6.2 - dose massima specificare: giornaliera----1件: 86 💬
167Dapagliflozin1件: Dapagliflozin1件: Dapagliflozin 💬 --10件: 6, 28, 49, 66, 67, 86, 88, 215, 218, 222 💬
168Dhea tablet1件: Prasterone1件: Prasterone 💬 3件: AR,
ESR1,
ESR2 💬 		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 86 💬
169Dichloroacetate sodium2件: Dichloroacetic acid,
Sodium dichloroacetate		1件: Sodium dichloroacetate 💬 3件: PDK2_3_4,
PDK2_3_4,
PDK2_3_4 💬 		1件: Diabetic cardiomyopathy 💬1件: 86 💬
170Dietanolamina DE treprostinilo1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
171Diltiazem hydrochloride1件: Diltiazem3件: Diltiazem hydrochloride ,
Diltiazem malate ,
Diltiazem 💬 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
172Dimethyl fumarate1件: Dimethyl fumarate1件: Dimethyl fumarate 💬 1件: KLHL19 💬 6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬5件: 13, 20, 51, 86, 296 💬
173Diphenhydramine1件: Diphenhydramine4件: Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬10件: 13, 19, 49, 51, 70, 86, 96, 222, 256, 300 💬
174Dobutamine test1件: Dobutamine3件: Dobutamine hydrochloride ,
Dobutamine ,
Dobutamine tartrate 💬 		1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
175Dose A KER-012----1件: 86 💬
176Dose B KER-012----1件: 86 💬
177Dose C KER-012----1件: 86 💬
178DUO-therapy with sildenafil + bosentan----1件: 86 💬
179E-learning----1件: 86 💬
180EFI/ACT-385781A----1件: 86 💬
181Elafin1件: Elafin---1件: 86 💬
182Emea/H/C/002677----1件: 86 💬
183Empagliflozin1件: Empagliflozin1件: Empagliflozin 💬 --10件: 65, 67, 72, 77, 86, 96, 97, 257, 298, 299 💬
184Empagliflozin 10 MG1件: Empagliflozin1件: Empagliflozin 💬 --4件: 58, 67, 86, 97 💬
185Empagliflozin IN treatment pulmonary aerterial hypertension1件: Empagliflozin1件: Empagliflozin 💬 --1件: 86 💬
186Endogenous thrombin potential----2件: 86, 88 💬
187Endothelin receptor antagonist therapy----1件: 86 💬
188Endothelin receptor antagonists----1件: 86 💬
189Endothelin-3----1件: 86 💬
190Enos transfected epcs will BE delivered VIA A PA line----1件: 86 💬
191Epicatechin1件: Epicatechin---2件: 86, 113 💬
192Epoprostenol1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
193Epoprostenol FOR injection1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
194Epoprostenol sodico1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
195Epoprostenol sodium1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
196Epoprostenol-actelion1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
197Epoprostenolo PER iniezione----1件: 86 💬
198ERA AS specific PAH treatment----1件: 86 💬
199Erbitux1件: Cetuximab1件: Cetuximab 💬 1件: EGFR 💬 47件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Virion - Hepatitis viruses 💬3件: 51, 86, 121 💬
200Esomeprazole1件: Esomeprazole5件: Esomeprazole magnesium ,
Esomeprazole sodium ,
Esomeprazole ,
Esomeprazole strontium ,
Esomeprazole magnesium dihydrate 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬9件: 6, 13, 46, 86, 98, 107, 113, 298, 299 💬
201ESR-specific PET scan----1件: 86 💬
202Esuberaprost1件: Esuberaprost2件: Esuberaprost ,
Esuberaprost sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
203Eutonic treprostinil solution----1件: 86 💬
204Famotidine 20 MG1件: Famotidine1件: Famotidine 💬 1件: HRH2 💬 4件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 86 💬
205FDC macitentan/tadalafil2件: Macitentan,
Tadalafil		2件: Tadalafil ,
Macitentan 💬 		3件: EDNRA,
EDNRB,
PDE5 💬 		10件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
206Ferinject1件: Ferric carboxymaltose1件: Ferric carboxymaltose 💬 --3件: 86, 97, 299 💬
207Ferinject or cosmofer----1件: 86 💬
208Ferric carboxymaltose1件: Ferric carboxymaltose1件: Ferric carboxymaltose 💬 --4件: 86, 96, 97, 299 💬
209Ferricarboxymaltose----1件: 86 💬
210FK506 level 2-3 NG/ML----1件: 86 💬
211FK506 level 3-5 NG/ML----1件: 86 💬
212FK506 level < 2 NG/ML----1件: 86 💬
213Flolan injection with currently marketed diluent----1件: 86 💬
214Flolan injection with reformulated diluent----1件: 86 💬
215Flolan TM and glycine diluent1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
216Flolan™ and glycine diluent1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
217Fluoxetine1件: Fluoxetine2件: Fluoxetine ,
Fluoxetine hydrochloride 💬 		1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬3件: 13, 17, 86 💬
218Forxiga1件: Dapagliflozin1件: Dapagliflozin 💬 --2件: 86, 88 💬
219Fulvestrant1件: Fulvestrant1件: Fulvestrant 💬 2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 86 💬
220Furosemide1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬2件: 77, 86 💬
221G04be03----1件: 86 💬
222G04be08----1件: 86 💬
223Gadolinium1件: Gadolinium---4件: 46, 77, 86, 305 💬
224GB002----1件: 86 💬
225GB002 capsules----1件: 86 💬
226Generic DRY powder inhaler----1件: 86 💬
227Gereic DRY powder inhaler----1件: 86 💬
228Glivec1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬2件: 51, 86 💬
229Glivec 100 MG comprimidos recubiertos CON PELícula1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬2件: 34, 86 💬
230Glivec 100 MG filmtabletten1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬2件: 51, 86 💬
231Glivec 100 MG hartkapsel1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
232Glivec® 100 MG filmtabletten1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
233GMA301 injection----1件: 86 💬
234GS-4997 18 MG----1件: 86 💬
235GS-4997 2 MG----1件: 86 💬
236GS-4997 6 MG----1件: 86 💬
237GSK1325760----2件: 86, 88 💬
238GSK1325760A----1件: 86 💬
239GSK22560981件: GSK2256098---1件: 86 💬
240GSK2586881----1件: 86 💬
241HGP1206----1件: 86 💬
242HS135----1件: 86 💬
243Hydroxyurea1件: Hydroxyurea1件: Hydroxyurea 💬 1件: RRM2 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬10件: 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
244Hyperpolarized 129XE----1件: 86 💬
245Hyperpolarized 13C-pyruvate----1件: 86 💬
246Hyperpolarized XE129----5件: 51, 85, 86, 88, 299 💬
247Hypotonictreprostinil solution----1件: 86 💬
248I-NEB AAD system----1件: 86 💬
249I.V. selexipag1件: Selexipag1件: Selexipag 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
250IKT-001PRO1件: IKT-001Pro---1件: 86 💬
251IL-61件: Human interleukin-6---3件: 46, 49, 86 💬
252Ilomedin 20----1件: 86 💬
253Iloprost1件: Iloprost2件: Iloprost ,
Iloprost tromethamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬4件: 51, 84, 85, 86 💬
254Iloprost PD-151件: Iloprost2件: Iloprost ,
Iloprost tromethamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
255Iloprost PD-61件: Iloprost2件: Iloprost ,
Iloprost tromethamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
256Imatinib1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬8件: 34, 35, 46, 51, 85, 86, 87, 162 💬
257Imatinib mesilate1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬3件: 13, 86, 88 💬
258Imatinib mesylate1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬5件: 13, 28, 34, 51, 86 💬
259Inhaled nitric oxide----2件: 85, 86 💬
260Inhaled nitric oxide & inopulse delivery1件: Nitric Oxide1件: Nitric oxide 💬 --1件: 86 💬
261Inhaled nitric oxide 75 MCG/KG IBW/HR----2件: 85, 86 💬
262Inhaled NO with pulsed delivery----1件: 86 💬
263Inhaled prostacyclin1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
264Inhaled treprostinil1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬3件: 84, 85, 86 💬
265INO----2件: 85, 86 💬
266INS1009----1件: 86 💬
267Intravenous administration OF ferric carboxymaltose----1件: 86 💬
268Intravenous infusion----3件: 6, 51, 86 💬
269Intravenous treprostinil----1件: 86 💬
270Intravenous/subcutaneous treprostinil----1件: 86 💬
271Iron supplement----1件: 86 💬
272Jardiance1件: Empagliflozin1件: Empagliflozin 💬 --2件: 65, 86 💬
273JNJ-67896049----1件: 86 💬
274JNJ-67896062 / ACT-064992----2件: 86, 88 💬
275JNJ-67896062/ACT-064922----1件: 86 💬
276JTT-2511件: JTT-251---1件: 86 💬
277KAR5585 capsules----1件: 86 💬
278L-carnitine1件: Levocarnitine2件: Levocarnitine chloride ,
Levocarnitine 💬 		--5件: 13, 46, 86, 96, 240 💬
279L-citrulline malate----1件: 86 💬
280L01xe01----1件: 86 💬
281L606 (liposomal treprostinil) inhalation solution 51UG----1件: 86 💬
282L606 inhalation system----1件: 86 💬
283L608 inhalation solution----1件: 86 💬
284L608 liposomal inhalation solution----1件: 86 💬
285Levitra1件: Vardenafil2件: Vardenafil ,
Vardenafil hydrochloride 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 13, 86 💬
286Lidocaine1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬10件: 6, 13, 22, 46, 86, 107, 168, 226, 231, 256 💬
287Light transmission aggregometry----2件: 86, 88 💬
288LIQ861 100 µG----1件: 86 💬
289LIQ861 106 µG----1件: 86 💬
290LIQ861 25 µG----1件: 86 💬
291LIQ861 26.5 µG----1件: 86 💬
292LIQ861 50 µG----1件: 86 💬
293LIQ861 53 µG----1件: 86 💬
294LIQ861 75 µG----1件: 86 💬
295LIQ861 79.5 µG----1件: 86 💬
296LIQ861 inhaled treprostinil----1件: 86 💬
297Lisuride1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 86 💬
298LTP----1件: 86 💬
299LTP001----2件: 85, 86 💬
300LY450190----1件: 86 💬
301Macitentan1件: Macitentan1件: Macitentan 💬 2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 51, 85, 86, 88, 210 💬
302Macitentan 10 MG1件: Macitentan1件: Macitentan 💬 2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 86, 88 💬
303Macitentan 37.5 MG1件: Macitentan1件: Macitentan 💬 2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
304Macitentan 75 MG1件: Macitentan1件: Macitentan 💬 2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
305Macitentan compresse1件: Macitentan1件: Macitentan 💬 2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 86, 88 💬
306Macitentan group1件: Macitentan1件: Macitentan 💬 2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
307Macitentan tablets1件: Macitentan1件: Macitentan 💬 2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 86, 88 💬
308Macitentan tablets 1件: Macitentan1件: Macitentan 💬 2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 86, 88 💬
309Medical AIR1件: Medical air1件: Air, medical 💬 --2件: 85, 86 💬
310Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬16件: 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202 💬
311Metformin1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬23件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
312Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo----1件: 86 💬
313Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo [3,4-B]pyridine-3-YL]-5-pyrimidinyl(methyl)carb----2件: 86, 88 💬
314Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-B]pyridin-3-YL]-5-pyrimidinyl]meth----2件: 86, 88 💬
315Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
316Mhealth intervention----1件: 86 💬
317MK-4836----2件: 86, 88 💬
318MK-5475----1件: 86 💬
319MK-7962----1件: 86 💬
320MK-8892----1件: 86 💬
321MN-08 24 MG/DAY----1件: 86 💬
322MN-08 60 MG/DAY----1件: 86 💬
323MONO-therapy with sildenafil----1件: 86 💬
324Morphine sulfate1件: Morphine4件: Morphine sulfate ,
Morphine hydrochloride hydrate ,
Morphine ,
Morphine tartrate 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬3件: 46, 85, 86 💬
325Moxifloxacin 400 MG1件: Moxifloxacin3件: Moxifloxacin hydrochloride ,
Moxifloxacin ,
Moxifloxacin hydrochloride monohydrate 💬 		--1件: 86 💬
326MTT with antibiotic preconditioning + fiber supplementation----1件: 86 💬
327Multihance----2件: 86, 88 💬
328Nebulized combination ipratropium bromide with salbutamol----1件: 86 💬
329Nebulized ipratropium bromide----1件: 86 💬
330NEW thermo stable formulation OF epoprostenol sodium1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
331Nicardipine1件: Nicardipine2件: Nicardipine hydrochloride ,
Nicardipine 💬 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 70, 86 💬
332Nilotinib1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬4件: 6, 34, 51, 86 💬
333Nilotinib 50 MG1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
334Nitric oxide1件: Nitric Oxide1件: Nitric oxide 💬 --8件: 51, 85, 86, 88, 97, 210, 294, 299 💬
335Nitric oxide FOR inhalation1件: Nitric Oxide1件: Nitric oxide 💬 --2件: 86, 299 💬
336Nitric oxide generated BY THE geno nitrosyl delivery system1件: Nitric Oxide1件: Nitric oxide 💬 --1件: 86 💬
337Nitric oxide plus oxygen2件: Nitric Oxide,
Oxygen		2件: Oxygen ,
Nitric oxide 💬 		--1件: 86 💬
338NON-biologic dmards----3件: 46, 86, 107 💬
339Noninvasive actigraphy monitor----1件: 86 💬
340NS-304----1件: 86 💬
341NX1011----1件: 86 💬
342Observational study with patients treated with tracleer, ventavis, veletri, opsumit and/or uptravi----1件: 86 💬
343Olaparib1件: Olaparib1件: Olaparib 💬 2件: PARP1,
PARP2 💬 		5件: Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis 💬2件: 86, 285 💬
344Opsumit1件: Macitentan1件: Macitentan 💬 2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 86, 88 💬
345Opsumit®1件: Macitentan1件: Macitentan 💬 2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 86, 88 💬
346Optional muscle biopsy----1件: 86 💬
347Oral anticoagulant treatment----1件: 86 💬
348Oral ERA----1件: 86 💬
349Oral ifetroban----2件: 51, 86 💬
350Oral PDE5 inhibitors----1件: 86 💬
351Oral sildenafil----1件: 86 💬
352Oral treprostinil----2件: 51, 86 💬
353Oral treprostinil (UT-15C) sustained release tablets----1件: 86 💬
354Oral zamicastat----1件: 86 💬
355Ossido nitrico----1件: 86 💬
356Oxacom----1件: 86 💬
357Oxygen1件: Oxygen1件: Oxygen 💬 --13件: 22, 49, 70, 85, 86, 88, 149, 168, 235, 271, 298, 299, 330 💬
358Oxygen supplementation1件: Oxygen1件: Oxygen 💬 --1件: 86 💬
359Oxygen, liquid1件: Oxygen1件: Oxygen 💬 --2件: 86, 88 💬
360PAH----1件: 86 💬
361PAH medication----1件: 86 💬
362Parenteral remodulin (treprostinil) injection----1件: 86 💬
363Parenteral treprostinil----1件: 86 💬
364Passive LEG raising----1件: 86 💬
365PB1046 subcutaneous injection----1件: 86 💬
366PB1046, VIP-ELP1-120, vasomera1件: Vasomera---1件: 86 💬
367PDE5 inhibitor----1件: 86 💬
368Pemziviptadil (PB1046) injection1件: Vasomera---1件: 86 💬
369PET-CT imaging with [89ZR]-bevacizumab----1件: 86 💬
370PET/CT scan: TWO PET scans using 1. C-11 HED and 2. N-13 ammonia or rubidium-82----1件: 86 💬
371PF-004897911件: PF-00489791---1件: 86 💬
372PF-07868489----1件: 86 💬
373Pioglitazone1件: Pioglitazone2件: Pioglitazone hydrochloride ,
Pioglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬16件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 220, 229, 265, 298, 299 💬
374Platelet function analyzer-100----2件: 86, 88 💬
375PLX-PAD1件: PLX-PAD---1件: 86 💬
376Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
377Preservative-free parenteral treprostinil----1件: 86 💬
378Prostacyclin1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
379Prostacyclin receptor agonist1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
380PURI-nethol----3件: 86, 96, 97 💬
381QCC374----1件: 86 💬
382QCC374 0.015 MG----1件: 86 💬
383QCC374 0.06 MG----1件: 86 💬
384QTI571----1件: 86 💬
385Qutenza1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 86 💬
386Ralinepag1件: Ralinepag1件: Ralinepag 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
387Ranolazine1件: Ranolazine2件: Ranolazine ,
Ranolazine hydrochloride 💬 		--7件: 2, 58, 86, 96, 97, 113, 114 💬
388Rapamycin1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬19件: 2, 15, 34, 35, 46, 49, 51, 53, 60, 61, 63, 67, 86, 96, 158, 193, 256, 279, 283 💬
389Rapid dose titration group OF subcutaneous treprostinil----1件: 86 💬
390Recombinant human angiotensin-converting enzyme 2 (ACE2), APN011件: Alunacedase alfa---1件: 86 💬
391Remodulin1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
392Remodulin® (treprostinil) 1 MG/ML solution FOR infusion1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
393Remodulin® (treprostinil) 10 MG/ML solution FOR infusion1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
394Remodulin® (treprostinil) 2.5 MG/ML solution FOR infusion1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
395Remodulin® (treprostinil) 5 MG/ML solution FOR infusion1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
396Revatio1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
397Revatio 10 MG/ML powder FOR oral suspension1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
398Revatio 20 MG film coated tablets1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
399Revatio 20 MG FILM-coated tablets----1件: 86 💬
400Revatio 20 MG filmtabletten1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
401Revatio 20 MG, comprimidos recubiertos CON PELícula1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
402Revatio inyectable1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
403Revatio oral1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
404Revatio POS1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
405Revatio tablets1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
406Riciguat group----1件: 86 💬
407Rifampin1件: Rifampin2件: Rifampin ,
Rifampicin sodium 💬 		--4件: 13, 84, 86, 299 💬
408Right heart catheterization (RHC) while exercising----1件: 86 💬
409Riociguat1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬6件: 51, 84, 86, 88, 225, 299 💬
410Riociguat 0.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
411Riociguat 1.0 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
412Riociguat 1.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
413Riociguat 2.0 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
414Riociguat 2.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
415Riociguat film coated tablets1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
416Riociguat granules 0.3% FOR oral application1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
417Riociguat oral product1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
418Riociguat oral tablet1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬3件: 51, 86, 88 💬
419Riociguat pill1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
420Ritonavir1件: Ritonavir1件: Ritonavir 💬 --3件: 2, 86, 265 💬
421Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
422RO 47-0203----4件: 51, 85, 86, 88 💬
423RO-47-0203----1件: 86 💬
424RO-47-0203/029----1件: 86 💬
425Roactemra1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬7件: 41, 44, 46, 51, 86, 107, 271 💬
426Rodatristat ethyl2件: Rodatristat,
Rodatristat ethyl		2件: Rodatristat ,
Rodatristat ethyl 💬 		1件: TPH1_2 💬 3件: Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬1件: 86 💬
427Rodatristat ethyl 300 MG tablet BID2件: Rodatristat,
Rodatristat ethyl		2件: Rodatristat ,
Rodatristat ethyl 💬 		1件: TPH1_2 💬 3件: Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬1件: 86 💬
428Rodatristat ethyl 600 MG BID2件: Rodatristat,
Rodatristat ethyl		2件: Rodatristat ,
Rodatristat ethyl 💬 		1件: TPH1_2 💬 3件: Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬1件: 86 💬
429Rotational thromboelastometry----2件: 86, 88 💬
430RT234 - vardenafil inhalation powder----1件: 86 💬
431RTA 402----3件: 67, 86, 218 💬
432RVG 33865----1件: 86 💬
433RVT-1201----1件: 86 💬
434Salbutamol1件: Albuterol2件: Albuterol sulfate ,
Albuterol 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬9件: 2, 3, 85, 86, 228, 256, 273, 299, 340 💬
435Saline1件: Sodium chloride1件: Sodium chloride 💬 --19件: 2, 6, 13, 17, 18, 46, 53, 67, 77, 86, 96, 97, 98, 168, 256, 271, 274, 299, 301 💬
436Sapropterin1件: Sapropterin2件: Sapropterin dihydrochloride ,
Sapropterin 💬 		--3件: 86, 124, 240 💬
437Saquinavir and ritonavir1件: Saquinavir2件: Saquinavir ,
Saquinavir mesylate 💬 		--1件: 86 💬
438Satralizumab1件: Satralizumab1件: Satralizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬4件: 11, 13, 86, 113 💬
439Sauerstoff----2件: 86, 88 💬
440Selexipag1件: Selexipag1件: Selexipag 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬6件: 47, 51, 70, 84, 86, 88 💬
441Selexipag film coated tablets1件: Selexipag1件: Selexipag 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
442Selonsertib1件: Selonsertib1件: Selonsertib 💬 1件: MAP3K5 💬 19件: Alcoholic liver disease, Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Huntington disease, Lipid and atherosclerosis, MAPK signaling pathway, Neurotrophin signaling pathway, Non-alcoholic fatty liver disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Protein processing in endoplasmic reticulum, Sphingolipid signaling pathway, Spinocerebellar ataxia, TNF signaling pathway, Thermogenesis, Tight junction 💬1件: 86 💬
443Seralutinib1件: Seralutinib1件: Seralutinib 💬 2件: PDGFRA,
PDGFRB 💬 		20件: Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Focal adhesion, Gap junction, Glioma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬1件: 86 💬
444Serine1件: Serine1件: Serine 💬 --1件: 86 💬
445Sham oxygen therapy----2件: 86, 88 💬
446Sham padn----1件: 86 💬
447Sildenaf----1件: 86 💬
448Sildenafil1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬14件: 6, 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬
449Sildenafil (revatio) 20 MG TID1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
450Sildenafil 20MG and bosentan 62.5MG1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
451Sildenafil citrate1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬4件: 51, 85, 86, 225 💬
452Sildenafil filmtabletten1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
453Sildenafil singly or IN association with bosentan1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
454Sildenafilo1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
455Simvastatin1件: Simvastatin1件: Simvastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 158, 160, 195, 265, 288, 298, 299, 310 💬
456Simvastatin 40 MG tablets1件: Simvastatin1件: Simvastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 86 💬
457Sirolimus1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬39件: 6, 13, 15, 19, 21, 34, 35, 36, 46, 48, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 97, 98, 137, 157, 158, 192, 222, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
458Sitaxentan1件: Sitaxentan2件: Sitaxentan ,
Sitaxentan sodium 💬 		1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
459Sitaxentan sodium1件: Sitaxentan2件: Sitaxentan ,
Sitaxentan sodium 💬 		1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
460Sitaxsentan1件: Sitaxentan2件: Sitaxentan ,
Sitaxentan sodium 💬 		1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
461Sitaxsentan alone1件: Sitaxentan2件: Sitaxentan ,
Sitaxentan sodium 💬 		1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
462Sitaxsentan and sildenafil1件: Sitaxentan2件: Sitaxentan ,
Sitaxentan sodium 💬 		1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
463Sitaxsentan sodium1件: Sitaxentan2件: Sitaxentan ,
Sitaxentan sodium 💬 		1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
464Slow dose titration group OF subcutaneous treprostinil----1件: 86 💬
465Sodium nitrite----2件: 86, 299 💬
466Sodium nitrite inhalation solution----1件: 86 💬
467Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20MG sildenafil citrate BY mouth1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
468Sorafenib1件: Sorafenib2件: Sorafenib tosylate ,
Sorafenib 💬 		8件: BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬 		87件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬2件: 34, 86 💬
469Sotatercept1件: Sotatercept1件: Sotatercept 💬 1件: ACVR2A 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 86 💬
470Sotatercept - 45 MG/vial1件: Sotatercept1件: Sotatercept 💬 1件: ACVR2A 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 86 💬
471Sotatercept - 60 MG/vial1件: Sotatercept1件: Sotatercept 💬 1件: ACVR2A 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 86 💬
472Spironolactone1件: Spironolactone1件: Spironolactone 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬7件: 46, 58, 67, 86, 113, 210, 225 💬
473Spironolactone and conivaptan1件: Spironolactone1件: Spironolactone 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬1件: 86 💬
474Standard OF care - double oral----1件: 86 💬
475Standard-OF-care----2件: 13, 86 💬
476Standardized meals----1件: 86 💬
477STI571----2件: 51, 86 💬
478Subacute hypoxic exposures----1件: 86 💬
479Subcutaneous and intravenous prostacyclin1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
480Subcutaneous treprostinil----1件: 86 💬
481Sugar pill----9件: 5, 6, 49, 67, 70, 86, 90, 206, 210 💬
482Sulfasalazine1件: Sulfasalazine1件: Sulfasalazine 💬 --6件: 46, 86, 94, 107, 270, 271 💬
483Supplemental oxygen therapy----2件: 86, 88 💬
484Tadalafil1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬7件: 6, 51, 75, 77, 84, 86, 113 💬
485Tadalafil 20 MG FILM-coated tablets1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
486Tadalafil 40 MG1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
487Tadalafil and ambrisentan upfront combination therapy1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
488Tadalafil mimic1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
489Tadalafil oral suspension1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
490Tadalafil- tablet or oral suspension1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
491Tadalafilo1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
492Tamoxifen1件: Tamoxifen2件: Tamoxifen citrate ,
Tamoxifen 💬 		2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬4件: 2, 86, 113, 227 💬
493Tasigna1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬2件: 34, 86 💬
494Tasigna® 150 MG1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
495TBD----5件: 19, 86, 90, 276, 299 💬
496Tegaderm----1件: 86 💬
497Terguride 0,5MG tablet1件: Terguride1件: Terguride 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 86 💬
498Terguride 0.5 MG tablet1件: Terguride1件: Terguride 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 86 💬
499Tezosentan1件: Tezosentan---1件: 86 💬
500Thelin1件: Sitaxentan2件: Sitaxentan ,
Sitaxentan sodium 💬 		1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
501Threonine1件: Threonine1件: Threonine 💬 --3件: 86, 96, 97 💬
502Tocilizumab1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬24件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
503Tolvaptan1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬4件: 67, 72, 86, 225 💬
504TPN171H----1件: 86 💬
505TPN171H single dose----1件: 86 💬
506Traclear----1件: 86 💬
507Tracleer1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 13, 51, 84, 85, 86, 88, 210, 211 💬
508Tracleer tablet FOR oral suspension1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
509Tracleer*56CPR RIV 125MG1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 86, 88 💬
510Transdihydrolisuride----2件: 51, 86 💬
511TRE----1件: 86 💬
512Treprosinil diethanolamine----1件: 86 💬
513Treprostin----1件: 86 💬
514Treprostinil1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬3件: 85, 86, 210 💬
515Treprostinil dietanolamina1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
516Treprostinil diethanolamine1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬2件: 51, 86 💬
517Treprostinil diolamine1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
518Treprostinil inhalation powder1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
519Treprostinil inhalations1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
520Treprostinil injectable product1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
521Treprostinil palmitil2件: Treprostinil,
Treprostinil palmitil		4件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine ,
Treprostinil palmitil 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
522Treprostinil palmitil inhalation powder2件: Treprostinil,
Treprostinil palmitil		4件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine ,
Treprostinil palmitil 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
523Treprostinil palmitil inhalation powder - 160 microgram2件: Treprostinil,
Treprostinil palmitil		4件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine ,
Treprostinil palmitil 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
524Treprostinil palmitil inhalation powder - 320 microgram2件: Treprostinil,
Treprostinil palmitil		4件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine ,
Treprostinil palmitil 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
525Treprostinil palmitil inhalation powder - 80 microgram2件: Treprostinil,
Treprostinil palmitil		4件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine ,
Treprostinil palmitil 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
526Treprostinil sodium1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬3件: 51, 86, 88 💬
527Treprostinil sodium solution FOR inhalation1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
528Treprostinil sodium, UT-151件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
529Treprostinil VIA implanted pump1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
530Treprostinil, UT-15, LRX-15, 15au81, BW A15AU, U-62, 8401件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
531Trimetazidine1件: Trimetazidine2件: Trimetazidine hydrochloride ,
Trimetazidine 💬 		--3件: 2, 58, 86 💬
532Triple-combination therapy----1件: 86 💬
533TRK-100STP----1件: 86 💬
534Tyrosine1件: Tyrosine1件: Tyrosine 💬 --2件: 6, 86 💬
535Tyvaso inhalation solution----1件: 86 💬
536Ubenimex1件: Ubenimex1件: Ubenimex 💬 1件: ANPEP 💬 3件: Glutathione metabolism, Hematopoietic cell lineage, Renin-angiotensin system 💬1件: 86 💬
537Udenafil1件: Udenafil1件: Udenafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 210 💬
538UK 092480----1件: 86 💬
539UK-92,480----1件: 86 💬
540UK-92,480-10----1件: 86 💬
541Ularitide1件: Ularitide---1件: 86 💬
542Uptravi1件: Selexipag1件: Selexipag 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬3件: 84, 86, 88 💬
543Uptravi® film coated tablets1件: Selexipag1件: Selexipag 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
544Urodilatin----1件: 86 💬
545UT-15C----1件: 86 💬
546UT-15C 0.25 MG----1件: 86 💬
547UT-15C 1 MG----1件: 86 💬
548UT-15C 5 MG----1件: 86 💬
549UT-15C LP----1件: 86 💬
550UT-15C SR----2件: 51, 86 💬
551UT-15C-SR----2件: 51, 86 💬
552Valsartan 40 MG1件: Valsartan1件: Valsartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
553Vardenafil1件: Vardenafil2件: Vardenafil ,
Vardenafil hydrochloride 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬3件: 13, 86, 299 💬
554Vasomera (PB1046) injection1件: Vasomera---1件: 86 💬
555Ventavis1件: Iloprost2件: Iloprost ,
Iloprost tromethamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
556Ventavis 101件: Iloprost2件: Iloprost ,
Iloprost tromethamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
557Vericiguat1件: Vericiguat1件: Vericiguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
558Viagra1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬3件: 86, 96, 225 💬
559VIP----3件: 49, 51, 86 💬
560Volibris1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 51, 85, 86, 88 💬
561Volibris 10 MG comprimidos recubiertos CON PELícula1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
562Volibris 5 MG comprimidos recubiertos CON PELícula1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
563Volibris™ tablets1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
564Warfarin1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬10件: 6, 8, 19, 46, 49, 66, 85, 86, 88, 91 💬
565Zamicastat1件: Zamicastat---1件: 86 💬